Kidney Care Access Protection Act
Take action
Record your position on this measure.
Create an account to take a stance, submit a written position, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Overview
The Kidney Care Access Protection Act aims to improve access to innovative treatments for end-stage renal disease under Medicare. It extends a transitional drug add-on payment adjustment for new renal dialysis drugs and biologicals, establishes a permanent add-on adjustment after that period, and expands eligibility for a similar adjustment to new and innovative equipment and supplies. The bill also ensures that Medicare Advantage plans support these innovative therapies and addresses staffing barriers within the kidney care payment system by adjusting for forecast error.
Key provisions
- Extends the transitional drug add-on payment adjustment for new renal dialysis drugs and biologicals for at least three years.
- Creates a permanent add-on payment adjustment for new renal dialysis drugs and biologicals after the transitional period.
- Expands the transitional add-on payment adjustment to include new and innovative equipment and supplies.
- Requires Medicare Advantage plans to make direct payment adjustments for covered innovative therapies.
- Adjusts the annual update of kidney care payment amounts to account for forecast error.
- Clarifies the definition of renal dialysis services to exclude drugs treating comorbid conditions.
- Addresses staffing barriers by adjusting the market basket labor adjustment.
- Requires the use of a modifier for claims involving new and innovative drugs.
Who is affected
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
3 on record
Primary sponsor
Cosponsors
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours